A detailed history of Ellevest, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Ellevest, Inc. holds 6,569 shares of EW stock, worth $430,138. This represents 0.04% of its overall portfolio holdings.

Number of Shares
6,569
Previous 6,272 4.74%
Holding current value
$430,138
Previous $599,000 1.17%
% of portfolio
0.04%
Previous 0.04%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$84.3 - $94.31 $25,037 - $28,010
297 Added 4.74%
6,569 $606,000
Q1 2024

May 13, 2024

BUY
$72.54 - $95.56 $11,098 - $14,620
153 Added 2.5%
6,272 $599,000
Q4 2023

Feb 06, 2024

SELL
$61.71 - $77.76 $29,991 - $37,791
-486 Reduced 7.36%
6,119 $466,000
Q3 2023

Nov 09, 2023

BUY
$69.28 - $93.38 $29,513 - $39,779
426 Added 6.89%
6,605 $457,000
Q2 2023

Aug 09, 2023

BUY
$81.41 - $94.33 $12,374 - $14,338
152 Added 2.52%
6,179 $582,000
Q1 2023

May 04, 2023

SELL
$74.26 - $84.51 $111,909 - $127,356
-1,507 Reduced 20.0%
6,027 $498,000
Q4 2022

Feb 03, 2023

SELL
$68.3 - $87.44 $67,821 - $86,827
-993 Reduced 11.65%
7,534 $562,000
Q3 2022

Nov 02, 2022

SELL
$82.37 - $107.29 $68,119 - $88,728
-827 Reduced 8.84%
8,527 $705,000
Q2 2022

Jul 18, 2022

SELL
$86.5 - $128.27 $15,829 - $23,473
-183 Reduced 1.92%
9,354 $889,000
Q1 2022

Apr 19, 2022

BUY
$101.96 - $128.34 $62,195 - $78,287
610 Added 6.83%
9,537 $1.12 Million
Q4 2021

Jan 24, 2022

BUY
$106.37 - $130.68 $15,742 - $19,340
148 Added 1.69%
8,927 $1.16 Million
Q3 2021

Oct 19, 2021

BUY
$102.91 - $122.75 $41,987 - $50,082
408 Added 4.87%
8,779 $994,000
Q2 2021

Jul 13, 2021

BUY
$83.84 - $104.76 $701,824 - $876,945
8,371 New
8,371 $867,000
Q1 2021

May 03, 2021

BUY
$78.68 - $90.67 $621,650 - $716,383
7,901 New
7,901 $661,000
Q4 2020

Feb 04, 2021

SELL
$71.69 - $91.23 $715,752 - $910,840
-9,984 Closed
0 $0
Q3 2020

Oct 26, 2020

BUY
$67.19 - $87.44 $46,697 - $60,770
695 Added 7.48%
9,984 $797,000
Q2 2020

Jul 06, 2020

BUY
$57.54 - $76.95 $363,537 - $486,170
6,318 Added 212.66%
9,289 $642,000
Q1 2020

Apr 13, 2020

BUY
$52.41 - $81.0 $153,246 - $236,844
2,924 Added 6221.28%
2,971 $560,000
Q4 2019

Feb 05, 2020

BUY
$71.7 - $82.09 $2,437 - $2,791
34 Added 261.54%
47 $11,000
Q3 2019

Oct 08, 2019

BUY
$61.55 - $75.43 $246 - $301
4 Added 44.44%
13 $3,000
Q2 2019

Aug 20, 2019

SELL
$55.74 - $64.41 $501 - $579
-9 Reduced 50.0%
9 $2,000
Q4 2018

Jan 25, 2019

BUY
$46.41 - $56.94 $835 - $1,024
18 New
18 $3,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Ellevest, Inc. Portfolio

Follow Ellevest, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ellevest, Inc. with notifications on news.